Abbott Laboratories 2014 Annual Report Download - page 36

Download and view the complete annual report

Please find page 36 of the 2014 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

ABBOTT 2014 ANNUAL REPORT
34
Year Ended December31 2014 2013 2012
Net Earnings $«2,284 $«2,576 $«5,963
Foreign currency translation (loss) adjustments (2,206) (239) (7)
Net actuarial gains (losses) and prior service cost and credits and amortization
of net actuarial losses and prior service cost and credits, net of taxes of
$(459) in 2014, $393 in 2013 and $(276) in 2012 (917) 882 (865)
Unrealized (losses) gains on marketable equity securities, net of taxes of
$(7) in 2014, $(10) in 2013 and $(4) in 2012 (12) (18) (7)
Net gains (losses) on derivative instruments designated as cash flow hedges,
net of taxes of $24 in 2014, $(13) in 2013 and $(29) in 2012 94 (53) (118)
Other Comprehensive Income (Loss) (3,041) 572 (997)
Comprehensive Income (Loss) $÷«(757) $«3,148 $«4,966
Supplemental Accumulated Other Comprehensive Income Information,
net of tax as of December31:
Cumulative foreign currency translation (loss) adjustments $(2,924) $÷«(718) $÷÷«(79)
Net actuarial (losses) and prior service (cost) and credits (2,229) (1,312) (3,596)
Cumulative unrealized gains on marketable equity securities 1 13 31
Cumulative gains on derivative instruments designated as cash flow hedges 99 5 50
The accompanying notes to consolidated financial statements are an integral part of this statement.
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
(inmillions)